Insider Transactions in Q3 2025 at Guardant Health, Inc. (GH)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2025
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,525
-1.84%
|
$76,250
$50.71 P/Share
|
|
Jul 01
2025
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,007
+1.8%
|
-
|
|
Jul 01
2025
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,714
-4.45%
|
$85,700
$50.71 P/Share
|
|
Jul 01
2025
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,381
+4.3%
|
-
|
|
Jul 01
2025
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,532
-3.04%
|
$76,600
$50.71 P/Share
|
|
Jul 01
2025
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,596
+3.51%
|
-
|
|
Jul 01
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,162
-0.5%
|
$608,100
$50.71 P/Share
|
|
Jul 01
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,997
+0.98%
|
-
|
|
Jul 01
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,162
-0.61%
|
$608,100
$50.71 P/Share
|
|
Jul 01
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,997
+1.19%
|
-
|
|
Jul 01
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-2.44%
|
$5,100,000
$51.04 P/Share
|